GLP-1RA Lipid-Specific Outcomes While the GLP-1RAs used for weight loss, semaglutide and tirzepatide, have garnered much focus, multiple other GLP-1RA medications have shown positive outcomes on lipid profiles: dulaglutide has shown reduction in total cholesterol and LDL-C [65], liraglutide has shown reduction in LDL-C and ApoCIII [66], and exenatide has shown reduction in LDL-C and total cholesterol and increase in HDL-C [67]
It helps regulate blood glucose by enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and promoting satiety
Unexpectedly, patients often report distinct subjective experiences of hunger and satiety on forums devoted to GLP-1 agonist non-responders, yet objective measures reveal minimal variation between response groups
Research applications include: GHRH receptor binding and pituitary stimulation studies
Thats where GLP-1 medications can help